{
  "doc_id": "7_administrationofnutritionsupport_part1__ff8a2c",
  "original_filename": "7_AdministrationofNutritionSupport,Part1.pdf",
  "md_path": "data/parsed/7_AdministrationofNutritionSupport,Part1/7_AdministrationofNutritionSupport,Part1.md",
  "rmd_path": "data/parsed/7_AdministrationofNutritionSupport,Part1/7_AdministrationofNutritionSupport,Part1.rmd",
  "blocks": [
    {
      "type": "heading",
      "level": 1,
      "section": "NUTRITION SUPPORT CERTIFICATE",
      "line": 0
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Administration of Nutrition Support, Part 1",
      "line": 2
    },
    {
      "type": "image",
      "section": "Administration of Nutrition Support, Part 1",
      "line": 4,
      "content": "![img-0.jpeg](images/412f1b1b557f1ba0.png)"
    },
    {
      "type": "text",
      "section": "Administration of Nutrition Support, Part 1",
      "line": 6,
      "preview": "Planned by the American Society of Health-System Pharmacists (ASHP) in collaboration with the Americ"
    },
    {
      "type": "text",
      "section": "Administration of Nutrition Support, Part 1",
      "line": 7,
      "preview": "(c)2022 American Society of Health-System Pharmacists, Inc. All rights reserved."
    },
    {
      "type": "text",
      "section": "Administration of Nutrition Support, Part 1",
      "line": 9,
      "preview": "No part of this publication may be reproduced or transmitted in any form or by any means, electronic"
    },
    {
      "type": "text",
      "section": "Administration of Nutrition Support, Part 1",
      "line": 11,
      "preview": "--- page 1 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ADMINISTRATION OF NUTRITION SUPPORT PART 1",
      "line": 13
    },
    {
      "type": "text",
      "section": "ADMINISTRATION OF NUTRITION SUPPORT PART 1",
      "line": 15,
      "preview": "Andrew Mays, Pharm.D., BCNSP, CNSC University of Mississippi Medical Center"
    },
    {
      "type": "text",
      "section": "ADMINISTRATION OF NUTRITION SUPPORT PART 1",
      "line": 17,
      "preview": "NUTRITION SUPPORT CERTIFICATE"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 19
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 21,
      "preview": "The following persons in control of this activity's content have relevant financial relationships:"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 23,
      "preview": "- Andrew Mays: Fresenius Kabi, speaker"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 25,
      "preview": "All other persons in control of content do not have any relevant financial relationships with an ine"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 27,
      "preview": "As defined by the Standards of Integrity and Independence definition of ineligible company. All rele"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 29,
      "preview": "--- page 2 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "LEARNING OBJECTIVES",
      "line": 31
    },
    {
      "type": "text",
      "section": "LEARNING OBJECTIVES",
      "line": 33,
      "preview": "- Review critical safety measures for initiating parenteral or enteral nutrition."
    },
    {
      "type": "text",
      "section": "LEARNING OBJECTIVES",
      "line": 34,
      "preview": "- Identify measures aimed at preventing tubing misconnections involving enteral and parenteral nutri"
    },
    {
      "type": "text",
      "section": "LEARNING OBJECTIVES",
      "line": 35,
      "preview": "- Discuss administration procedures for parenteral nutrition to prevent complications related to tub"
    },
    {
      "type": "text",
      "section": "LEARNING OBJECTIVES",
      "line": 36,
      "preview": "- Distinguish steps in managing TNA vs. 2-in-1 parenteral nutrition with separate lipid injectable e"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "KEY ABBREVIATIONS",
      "line": 39
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 41,
      "preview": "- EN:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 42,
      "preview": "- ICU:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 43,
      "preview": "- ILE:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 44,
      "preview": "- NKDA:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 45,
      "preview": "- PN:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 46,
      "preview": "- PPN:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 47,
      "preview": "- TNA:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 48,
      "preview": "enteral nutrition"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 49,
      "preview": "intensive care unit"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 50,
      "preview": "lipid injectable emulsion"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 51,
      "preview": "no known drug allergies"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 52,
      "preview": "parenteral nutrition"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 53,
      "preview": "peripheral parenteral nutrition"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 54,
      "preview": "total nutrient admixture"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 56,
      "preview": "--- page 3 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#1",
      "line": 58
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 60,
      "preview": "A 61-year-old woman with a history of Crohn's disease, develops persistent nausea and vomiting. X-ra"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 61,
      "preview": "A. Low residue oral diet"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 62,
      "preview": "B. Parenteral nutrition"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 63,
      "preview": "C. Peripheral intravenous fluids"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 64,
      "preview": "D. Tube feeding"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#2",
      "line": 66
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 68,
      "preview": "A 28 year old man was admitted to the ICU 7 days ago with multiple trauma following a motor vehicle "
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 69,
      "preview": "A. The osmolality limit for PPN is set at $600 \\mathrm{mOsm} / \\mathrm{L}$"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 70,
      "preview": "B. The expected duration of therapy should be greater than 2 weeks."
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 71,
      "preview": "C. PPN avoids the risks associated with central line placement"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 72,
      "preview": "D. PPN is most appropriate for use with hypermetabolic conditions"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 74,
      "preview": "--- page 4 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "THE FOUNDATION FOR SAFE NUTRITION SUPPORT PRACTICE",
      "line": 76
    },
    {
      "type": "text",
      "section": "THE FOUNDATION FOR SAFE NUTRITION SUPPORT PRACTICE",
      "line": 78,
      "preview": "- Collaborative interdisciplinary approaches"
    },
    {
      "type": "text",
      "section": "THE FOUNDATION FOR SAFE NUTRITION SUPPORT PRACTICE",
      "line": 79,
      "preview": "- Evidence-based policies and procedures"
    },
    {
      "type": "text",
      "section": "THE FOUNDATION FOR SAFE NUTRITION SUPPORT PRACTICE",
      "line": 80,
      "preview": "- Define the roles \\& responsibilities of all involved"
    },
    {
      "type": "text",
      "section": "THE FOUNDATION FOR SAFE NUTRITION SUPPORT PRACTICE",
      "line": 81,
      "preview": "- Avoid variations in practice"
    },
    {
      "type": "text",
      "section": "THE FOUNDATION FOR SAFE NUTRITION SUPPORT PRACTICE",
      "line": 82,
      "preview": "- Implement protocols"
    },
    {
      "type": "text",
      "section": "THE FOUNDATION FOR SAFE NUTRITION SUPPORT PRACTICE",
      "line": 83,
      "preview": "- Standardize procedures (Equipment, hang time, care of access device, etc)"
    },
    {
      "type": "text",
      "section": "THE FOUNDATION FOR SAFE NUTRITION SUPPORT PRACTICE",
      "line": 84,
      "preview": "- Address challenges to optimal delivery of nutrition support delivery"
    },
    {
      "type": "text",
      "section": "THE FOUNDATION FOR SAFE NUTRITION SUPPORT PRACTICE",
      "line": 85,
      "preview": "- Selection, insertion, and maintenance of access devices"
    },
    {
      "type": "text",
      "section": "THE FOUNDATION FOR SAFE NUTRITION SUPPORT PRACTICE",
      "line": 86,
      "preview": "- Correct environmental issues that contribute to errors"
    },
    {
      "type": "text",
      "section": "THE FOUNDATION FOR SAFE NUTRITION SUPPORT PRACTICE",
      "line": 87,
      "preview": "- Work flow issues, distractions"
    },
    {
      "type": "text",
      "section": "THE FOUNDATION FOR SAFE NUTRITION SUPPORT PRACTICE",
      "line": 88,
      "preview": "- Availability of supplies and equipment"
    },
    {
      "type": "text",
      "section": "THE FOUNDATION FOR SAFE NUTRITION SUPPORT PRACTICE",
      "line": 90,
      "preview": "Ayers P et al. JPEN J Parenter Enteral Nutr. 2014; 38(3):296-333."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 92
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 94,
      "preview": "Judicious selection of candidates"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 96,
      "preview": "Appropriate indication for nutrition support"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 98,
      "preview": "Decisions guided by results of assessment findings"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 100,
      "preview": "Evaluation of potential for complications"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 102,
      "preview": "- Interdisciplinary collaboration"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 103,
      "preview": "-Evidence based guidelines for indications"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 104,
      "preview": "-Patient and caregiver agreement"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 105,
      "preview": "- Assessment of risk versus benefit"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 106,
      "preview": "- Timing of intervention is consistent with guidelines"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 107,
      "preview": "- Nutrition plan is aligned with overall plan of care"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 108,
      "preview": "- Nutrition status"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 109,
      "preview": "- Gl function"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 110,
      "preview": "- Clinical and metabolic stability"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 111,
      "preview": "- Risk for complications of nutrition support access"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 112,
      "preview": "- Risk forrefeeding syndrome"
    },
    {
      "type": "text",
      "section": "INITIATING NUTRITION SUPPORT SAFELY",
      "line": 114,
      "preview": "--- page 5 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 116
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 118,
      "preview": "- Enteral nutrition is preferred when Gl tract is functional"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 119,
      "preview": "- Advantages of enteral nutrition"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 120,
      "preview": "- Relies on normal digestive pathways"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 121,
      "preview": "- Provides a more complete range of nutrients"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 122,
      "preview": "- Preserves integrity of the gut, especially immune factors"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 123,
      "preview": "- Associated with favorable outcomes compared to parenteral nutrition"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 124,
      "preview": "- Lower risk of infection"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 125,
      "preview": "- Fewer metabolic complications than IV route"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 126,
      "preview": "- Less expensive than parenteral nutrition"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 127,
      "preview": "- Reserve PN for situation where Gl function is inadequate"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 129,
      "preview": "GUIDELINES FOR PN INITIATION"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 131,
      "preview": "- Do not use based solely on medical diagnosis or disease state"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 132,
      "preview": "- Evaluate clinical factors from history, physical examination, and diagnostic evaluations in determ"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 133,
      "preview": "- Conduct a clinical review to assess PN appropriateness prior to compounding the PN admixture"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 134,
      "preview": "- Use PN in patients who are malnourished or at risk for malnutrition when:"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 135,
      "preview": "- A contraindication to EN exists OR"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 136,
      "preview": "- Patient cannot tolerate adequate EN OR"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 137,
      "preview": "- Lacks sufficient bowel function to maintain or restore nutrition status due to Gl dysfunction"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT GUIDELINES",
      "line": 139,
      "preview": "--- page 6 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "INDICATIONS FOR PARENTERAL NUTRITION",
      "line": 141
    },
    {
      "type": "heading",
      "level": 2,
      "section": "- Impaired absorption",
      "line": 143
    },
    {
      "type": "text",
      "section": "- Impaired absorption",
      "line": 145,
      "preview": "- short bowel syndrome, fistula"
    },
    {
      "type": "text",
      "section": "- Impaired absorption",
      "line": 146,
      "preview": "- Mechanical bowel obstruction"
    },
    {
      "type": "text",
      "section": "- Impaired absorption",
      "line": 147,
      "preview": "- stricture, tumor"
    },
    {
      "type": "text",
      "section": "- Impaired absorption",
      "line": 148,
      "preview": "- Motility disorders"
    },
    {
      "type": "text",
      "section": "- Impaired absorption",
      "line": 149,
      "preview": "- pseudo-obstruction, ileus, severe adhesive disease"
    },
    {
      "type": "text",
      "section": "- Impaired absorption",
      "line": 150,
      "preview": "- Need for bowel rest"
    },
    {
      "type": "text",
      "section": "- Impaired absorption",
      "line": 151,
      "preview": "- ischemic bowel, neutropenic colitis"
    },
    {
      "type": "text",
      "section": "- Impaired absorption",
      "line": 152,
      "preview": "- Inability to place or maintain safe enteral access"
    },
    {
      "type": "text",
      "section": "- Impaired absorption",
      "line": 154,
      "preview": "Worthington P et al. JPEN J Parenter Enter Nutr. 2017; 41:324-77."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "ASHLEY'S CASE",
      "line": 156
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 158,
      "preview": "- Age: 37 year-old female"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 159,
      "preview": "- Presents to the ED with fever, vomiting, and abdominal pain:"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 160,
      "preview": "- 1 day history of fever, malaise, and abdominal pain which progressed to two vomiting episodes in 6"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 161,
      "preview": "- No diarrhea"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 162,
      "preview": "- Subsequent work-up confirms acute pancreatitis"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 164,
      "preview": "CC Image courtesy of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). h"
    },
    {
      "type": "image",
      "section": "ASHLEY'S CASE",
      "line": 165,
      "content": "![img-1.jpeg](images/0670f8c9f5d1d19b.png)"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 167,
      "preview": "--- page 7 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ASHLEY'S CASE",
      "line": 169
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 171,
      "preview": "- Past medical history:"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 172,
      "preview": "- Short bowel syndrome (SBS) due to Crohn's disease (285 cm of functional small intestine and an int"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 173,
      "preview": "- Chronic diarrhea usually controlled by loperamide"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 174,
      "preview": "- Chronic anemia"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 175,
      "preview": "- Diet: Generally oral diet with oral supplements and vitamins"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 176,
      "preview": "- Current medications:"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 177,
      "preview": "- Azathioprine"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 178,
      "preview": "- Loperamide"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 179,
      "preview": "- Clonidine"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 180,
      "preview": "- Prenatal vitamin"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 181,
      "preview": "- Cyanocobalamin"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 182,
      "preview": "- Iron sucrose"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 183,
      "preview": "- NKDA"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "ASHLEY'S CASE",
      "line": 186
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 188,
      "preview": "- Vitals:"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 189,
      "preview": "- RR: 18 breaths/min"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 190,
      "preview": "- Pulse: 98-104 bpm, sinus tachycardia"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 191,
      "preview": "- BP: 106/65 mmHg"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 192,
      "preview": "- Temp: $101.5^{\\circ} \\mathrm{F}$"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 193,
      "preview": "- Weight: 62.5 kg (decreased 0.8 kg from baseline)"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 194,
      "preview": "- Height: 5'7\" (170.2 cm)"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 195,
      "preview": "- Body mass index: $21.5 \\mathrm{~kg} / \\mathrm{m}^{2}$"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE",
      "line": 197,
      "preview": "--- page 8 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF ASSESSMENT \\#4",
      "line": 199
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#4",
      "line": 201,
      "preview": "Is PN indicated upon admission for Ashley?"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#4",
      "line": 202,
      "preview": "A. Yes; because of SBS and/or Crohn's disease"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#4",
      "line": 203,
      "preview": "B. Yes; because of acute pancreatitis"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#4",
      "line": 204,
      "preview": "C. Yes; because of abdominal pain and vomiting"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#4",
      "line": 205,
      "preview": "D. No; because she tolerated an oral diet prior to admission"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF ASSESSMENT \\#4",
      "line": 207
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#4",
      "line": 209,
      "preview": "Is PN indicated upon admission for Ashley?"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#4",
      "line": 210,
      "preview": "A. Yes; because of SBS and/or Crohn's disease"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#4",
      "line": 211,
      "preview": "B. Yes; because of acute pancreatitis"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#4",
      "line": 212,
      "preview": "C. Yes; because of abdominal pain and vomiting"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#4",
      "line": 213,
      "preview": "D. No; because she tolerated an oral diet prior to admission"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#4",
      "line": 215,
      "preview": "Rationale: Gut was functional prior to admission; no contraindication to EN"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#4",
      "line": 217,
      "preview": "--- page 9 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 219
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 221,
      "preview": "- Oral diet not feasible"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 222,
      "preview": "- What is her malnutrition risk?"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 223,
      "preview": "- Weight change: No"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 224,
      "preview": "- Pre-admission intake: Adequate"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 225,
      "preview": "- Comorbidities: Controlled with medical management"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 226,
      "preview": "- No absolute or relative contraindication to EN"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "CONTRAINDICATIONS FOR EN",
      "line": 229
    },
    {
      "type": "text",
      "section": "CONTRAINDICATIONS FOR EN",
      "line": 231,
      "preview": "- Mechanical obstruction of the gastrointestinal tract"
    },
    {
      "type": "text",
      "section": "CONTRAINDICATIONS FOR EN",
      "line": 232,
      "preview": "- Uncontrolled peritonitis"
    },
    {
      "type": "text",
      "section": "CONTRAINDICATIONS FOR EN",
      "line": 233,
      "preview": "- Uncorrected coagulopathy or thrombocytopenia"
    },
    {
      "type": "text",
      "section": "CONTRAINDICATIONS FOR EN",
      "line": 234,
      "preview": "- Bowel ischemia"
    },
    {
      "type": "text",
      "section": "CONTRAINDICATIONS FOR EN",
      "line": 235,
      "preview": "- Recent gastrointestinal bleeding with high risk of recurrent bleeding (peptic ulcer disease or eso"
    },
    {
      "type": "text",
      "section": "CONTRAINDICATIONS FOR EN",
      "line": 236,
      "preview": "- Intractable nausea and diarrhea"
    },
    {
      "type": "text",
      "section": "CONTRAINDICATIONS FOR EN",
      "line": 238,
      "preview": "--- page 10 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 240
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 242,
      "preview": "- Admitted to the medical ICU, started on IV fluid for dehydration"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 243,
      "preview": "- Anti-emetics (ondansetron + diphenhydramine) for nausea and vomiting"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 244,
      "preview": "- Blood culture sent, result pending"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 245,
      "preview": "- Pain management"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 246,
      "preview": "- Post-pyloric feeding tube placed (past the ligament of Treitz)"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 247,
      "preview": "- EN to be started with a semi-elemental formula"
    },
    {
      "type": "image",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 248,
      "content": "![img-2.jpeg](images/8de4a22572ef49a5.png)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "VERIFICATION STEPS: EN AND PN",
      "line": 251
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN",
      "line": 253,
      "preview": "- Verification Procedures for Nutrition Support"
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN",
      "line": 255,
      "preview": "1. Confirm patient identity using 2 identifiers per organizational policy"
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN",
      "line": 256,
      "preview": "2. Match components of PN formulation or EN product label against prescriber order"
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN",
      "line": 257,
      "preview": "a) Product name, route, initiation time, rate of delivery and beyond use date"
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN",
      "line": 258,
      "preview": "3. Inspect container to detect defects or visual changes"
    },
    {
      "type": "image",
      "section": "VERIFICATION STEPS: EN AND PN",
      "line": 259,
      "content": "![img-3.jpeg](images/6b2234bd76218919.png)"
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN",
      "line": 261,
      "preview": "CC Image courtesy Shutterstock.com"
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN",
      "line": 263,
      "preview": "--- page 11 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "VERIFICATION STEPS: EN AND PN, CONT.",
      "line": 265
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN, CONT.",
      "line": 267,
      "preview": "- Verification Procedures for Nutrition Support"
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN, CONT.",
      "line": 269,
      "preview": "1. Verify correct access device"
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN, CONT.",
      "line": 270,
      "preview": "a. Confirmation of correct position prior to first dose, per organizational policy"
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN, CONT.",
      "line": 271,
      "preview": "b. EN: Gastric vs Jejunal"
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN, CONT.",
      "line": 272,
      "preview": "c. PN: Correct vascular device"
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN, CONT.",
      "line": 273,
      "preview": "i. Central vs peripheral"
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN, CONT.",
      "line": 274,
      "preview": "ii. Dedicated lumen"
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN, CONT.",
      "line": 275,
      "preview": "d. Confirm patency of access device"
    },
    {
      "type": "text",
      "section": "VERIFICATION STEPS: EN AND PN, CONT.",
      "line": 277,
      "preview": "Ayers P et al. JPEN J Parenter Enteral Nutr. 2014; 38(3):296-333."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF ASSESSMENT \\#5",
      "line": 279
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#5",
      "line": 281,
      "preview": "Tube feeding is about to be initiated via the NJ tube. The ICU nurse directs the feeding tube toward"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#5",
      "line": 282,
      "preview": "A. Allows the patient to see that she is receiving adequate nutrition"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#5",
      "line": 283,
      "preview": "B. Reduces the risk of tubing misconnections"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#5",
      "line": 284,
      "preview": "C. Avoids microbial contamination of the enteral formula"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#5",
      "line": 285,
      "preview": "D. Facilitates administration of medications with enteral formulation"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#5",
      "line": 287,
      "preview": "--- page 12 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF ASSESSMENT \\#5",
      "line": 289
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#5",
      "line": 291,
      "preview": "Tube feeding is about to be initiated via the NJ tube. The ICU nurse directs the feeding tube toward"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#5",
      "line": 292,
      "preview": "A. Allows the patient to see that she is receiving adequate nutrition"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#5",
      "line": 293,
      "preview": "B. Reduces the risk of tubing misconnections"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#5",
      "line": 294,
      "preview": "C. Avoids microbial contamination of the enteral formula"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#5",
      "line": 295,
      "preview": "D. Facilitates administration of medications with enteral formulation"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "THE DANGER OF TUBING MISCONNECTIONS",
      "line": 297
    },
    {
      "type": "text",
      "section": "THE DANGER OF TUBING MISCONNECTIONS",
      "line": 299,
      "preview": "- Issue: Universal Luer Connectors"
    },
    {
      "type": "text",
      "section": "THE DANGER OF TUBING MISCONNECTIONS",
      "line": 300,
      "preview": "- Allow connection of functionally dissimilar tubes and catheters"
    },
    {
      "type": "text",
      "section": "THE DANGER OF TUBING MISCONNECTIONS",
      "line": 301,
      "preview": "- Reports involve:"
    },
    {
      "type": "text",
      "section": "THE DANGER OF TUBING MISCONNECTIONS",
      "line": 302,
      "preview": "- IV catheters"
    },
    {
      "type": "text",
      "section": "THE DANGER OF TUBING MISCONNECTIONS",
      "line": 303,
      "preview": "- feeding tubes"
    },
    {
      "type": "text",
      "section": "THE DANGER OF TUBING MISCONNECTIONS",
      "line": 304,
      "preview": "- tracheostomy cuffs"
    },
    {
      "type": "text",
      "section": "THE DANGER OF TUBING MISCONNECTIONS",
      "line": 305,
      "preview": "- hemo/peritoneal dialysis tubes"
    },
    {
      "type": "text",
      "section": "THE DANGER OF TUBING MISCONNECTIONS",
      "line": 306,
      "preview": "- neuraxial catheters"
    },
    {
      "type": "text",
      "section": "THE DANGER OF TUBING MISCONNECTIONS",
      "line": 307,
      "preview": "- A persistent and potentially fatal event: 116 reports; 21 deaths"
    },
    {
      "type": "text",
      "section": "THE DANGER OF TUBING MISCONNECTIONS",
      "line": 309,
      "preview": "Simmons D et al. Nutr Clin Pract. 2011;26(3):286-93."
    },
    {
      "type": "text",
      "section": "THE DANGER OF TUBING MISCONNECTIONS",
      "line": 310,
      "preview": "The Joint Commission. https://www.jointcommission.org/sea_issue_53/ (accessed 2019 Mar 14)."
    },
    {
      "type": "image",
      "section": "THE DANGER OF TUBING MISCONNECTIONS",
      "line": 311,
      "content": "![img-4.jpeg](images/7667dd7a76027700.png)"
    },
    {
      "type": "text",
      "section": "THE DANGER OF TUBING MISCONNECTIONS",
      "line": 313,
      "preview": "--- page 13 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "THE DANGER OF TUBING MISCONNECTIONS, CONT.",
      "line": 315
    },
    {
      "type": "image",
      "section": "THE DANGER OF TUBING MISCONNECTIONS, CONT.",
      "line": 317,
      "content": "![img-5.jpeg](images/0701e704546ab79f.png)"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "RISK REDUCTION STRATEGIES",
      "line": 319
    },
    {
      "type": "text",
      "section": "RISK REDUCTION STRATEGIES",
      "line": 321,
      "preview": "1. Trace all lines back to their point of origin"
    },
    {
      "type": "text",
      "section": "RISK REDUCTION STRATEGIES",
      "line": 322,
      "preview": "2. Recheck connections and trace all lines as part of a handoff process"
    },
    {
      "type": "text",
      "section": "RISK REDUCTION STRATEGIES",
      "line": 323,
      "preview": "3. Never force connections"
    },
    {
      "type": "text",
      "section": "RISK REDUCTION STRATEGIES",
      "line": 324,
      "preview": "4. Designate route on product label"
    },
    {
      "type": "text",
      "section": "RISK REDUCTION STRATEGIES",
      "line": 325,
      "preview": "5. Label certain high-risk catheters as to the type of catheter"
    },
    {
      "type": "image",
      "section": "RISK REDUCTION STRATEGIES",
      "line": 326,
      "content": "![img-6.jpeg](images/f7fad7555b1a219f.png)"
    },
    {
      "type": "text",
      "section": "RISK REDUCTION STRATEGIES",
      "line": 328,
      "preview": "CC Image courtesy of the American Society for"
    },
    {
      "type": "text",
      "section": "RISK REDUCTION STRATEGIES",
      "line": 329,
      "preview": "Enteral and Parenteral Nutrition (ASPEN)"
    },
    {
      "type": "text",
      "section": "RISK REDUCTION STRATEGIES",
      "line": 331,
      "preview": "--- page 14 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "RISK REDUCTION STRATEGIES",
      "line": 333
    },
    {
      "type": "text",
      "section": "RISK REDUCTION STRATEGIES",
      "line": 335,
      "preview": "6. Route lines with different purposes in unique and standardized directions (e.g., route IV lines t"
    },
    {
      "type": "text",
      "section": "RISK REDUCTION STRATEGIES",
      "line": 336,
      "preview": "7. Global initiative for complete design change: System specific connectors - starting with enteral "
    },
    {
      "type": "text",
      "section": "RISK REDUCTION STRATEGIES",
      "line": 338,
      "preview": "GEDSA. ENFit\u00ae Advocacy Meeting. 2017 Jul."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "ENFIT\u00ae CONNECTORS: INCOMPATIBILITY BY DESIGN",
      "line": 340
    },
    {
      "type": "image",
      "section": "ENFIT\u00ae CONNECTORS: INCOMPATIBILITY BY DESIGN",
      "line": 342,
      "content": "![img-7.jpeg](images/b1a560055210e9ce.png)"
    },
    {
      "type": "text",
      "section": "ENFIT\u00ae CONNECTORS: INCOMPATIBILITY BY DESIGN",
      "line": 344,
      "preview": "CC Image courtesy of the Global Enteral Device Supplier Association."
    },
    {
      "type": "text",
      "section": "ENFIT\u00ae CONNECTORS: INCOMPATIBILITY BY DESIGN",
      "line": 346,
      "preview": "--- page 15 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ENFIT\u00ae CONVERSION CHALLENGES",
      "line": 348
    },
    {
      "type": "text",
      "section": "ENFIT\u00ae CONVERSION CHALLENGES",
      "line": 350,
      "preview": "- **Availability of adaptors**"
    },
    {
      "type": "text",
      "section": "ENFIT\u00ae CONVERSION CHALLENGES",
      "line": 351,
      "preview": "- Serve as a crutch"
    },
    {
      "type": "text",
      "section": "ENFIT\u00ae CONVERSION CHALLENGES",
      "line": 352,
      "preview": "- Perpetuate risks"
    },
    {
      "type": "text",
      "section": "ENFIT\u00ae CONVERSION CHALLENGES",
      "line": 353,
      "preview": "- **Delay rollout for modified syringe design**"
    },
    {
      "type": "text",
      "section": "ENFIT\u00ae CONVERSION CHALLENGES",
      "line": 354,
      "preview": "- Variation in dead space; risk for dose variation, especially in pediatrics"
    },
    {
      "type": "text",
      "section": "ENFIT\u00ae CONVERSION CHALLENGES",
      "line": 355,
      "preview": "- Work flow: How to deliver medication to clinical area (Type of tube? oral, ENFit\u00ae syringe or luer "
    },
    {
      "type": "text",
      "section": "ENFIT\u00ae CONVERSION CHALLENGES",
      "line": 356,
      "preview": "- Need for pharmacy equipment and supply overhaul"
    },
    {
      "type": "text",
      "section": "ENFIT\u00ae CONVERSION CHALLENGES",
      "line": 357,
      "preview": "- **Regulatory influence by FDA and The Joint Commission**"
    },
    {
      "type": "text",
      "section": "ENFIT\u00ae CONVERSION CHALLENGES",
      "line": 359,
      "preview": "*The Joint Commission. https://www.jointcommission.org/sea_issue_53/ (accessed 2019 Mar 14).*"
    },
    {
      "type": "image",
      "section": "ENFIT\u00ae CONVERSION CHALLENGES",
      "line": 361,
      "content": "![img-8.jpeg](images/9aa922bdfe71174f.png)"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ADMINISTRATION STEPS: EN AND PN",
      "line": 363
    },
    {
      "type": "text",
      "section": "ADMINISTRATION STEPS: EN AND PN",
      "line": 365,
      "preview": "- **Administration Procedures for Nutrition Support**"
    },
    {
      "type": "text",
      "section": "ADMINISTRATION STEPS: EN AND PN",
      "line": 366,
      "preview": "1. Verify correct pump settings as indicated"
    },
    {
      "type": "text",
      "section": "ADMINISTRATION STEPS: EN AND PN",
      "line": 367,
      "preview": "2. Two infusion pumps for dextrose/amino acids and ILE administered as a separate infusion"
    },
    {
      "type": "text",
      "section": "ADMINISTRATION STEPS: EN AND PN",
      "line": 368,
      "preview": "3. Double check settings with a second clinician per organizational policy"
    },
    {
      "type": "text",
      "section": "ADMINISTRATION STEPS: EN AND PN",
      "line": 369,
      "preview": "4. Adhere to sound infection control practices"
    },
    {
      "type": "text",
      "section": "ADMINISTRATION STEPS: EN AND PN",
      "line": 370,
      "preview": "- Hand hygiene"
    },
    {
      "type": "text",
      "section": "ADMINISTRATION STEPS: EN AND PN",
      "line": 371,
      "preview": "- Hang times"
    },
    {
      "type": "text",
      "section": "ADMINISTRATION STEPS: EN AND PN",
      "line": 372,
      "preview": "- EN hang times"
    },
    {
      "type": "text",
      "section": "ADMINISTRATION STEPS: EN AND PN",
      "line": 373,
      "preview": "- PN and lipid hang times"
    },
    {
      "type": "text",
      "section": "ADMINISTRATION STEPS: EN AND PN",
      "line": 375,
      "preview": "*Worthington P et al. JPEN J Parenter Enter Nutr. 2017;41:324-77.*"
    },
    {
      "type": "text",
      "section": "ADMINISTRATION STEPS: EN AND PN",
      "line": 377,
      "preview": "--- page 16 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "DOUBLE CHECK PUMP SETTINGS",
      "line": 379
    },
    {
      "type": "text",
      "section": "DOUBLE CHECK PUMP SETTINGS",
      "line": 381,
      "preview": "- Pump-related errors"
    },
    {
      "type": "text",
      "section": "DOUBLE CHECK PUMP SETTINGS",
      "line": 382,
      "preview": "- Wide use of multichannel pumps: enteral and parenteral"
    },
    {
      "type": "text",
      "section": "DOUBLE CHECK PUMP SETTINGS",
      "line": 383,
      "preview": "- Pump programming errors most common; potential for severe harm"
    },
    {
      "type": "text",
      "section": "DOUBLE CHECK PUMP SETTINGS",
      "line": 384,
      "preview": "- Double checks to verify pump settings"
    },
    {
      "type": "text",
      "section": "DOUBLE CHECK PUMP SETTINGS",
      "line": 385,
      "preview": "- Performed by 2 clinicians alone and apart from each other"
    },
    {
      "type": "text",
      "section": "DOUBLE CHECK PUMP SETTINGS",
      "line": 386,
      "preview": "- Expand to additional phases of nutrition support administration based on quality data, patient pop"
    },
    {
      "type": "text",
      "section": "DOUBLE CHECK PUMP SETTINGS",
      "line": 387,
      "preview": "- When administering the dextrose/amino acid component of the PN and the ILE as separate infusions, "
    },
    {
      "type": "text",
      "section": "DOUBLE CHECK PUMP SETTINGS",
      "line": 388,
      "preview": "Ayers P et al. JPEN J Parenter Enteral Nutr. 2014; 38(3):296-333."
    },
    {
      "type": "text",
      "section": "DOUBLE CHECK PUMP SETTINGS",
      "line": 389,
      "preview": "AHRQ. PSNet. https://psnet.ahrq.gov/cases/case/103 (accessed 2019 Mar 14)."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "PN ADMINISTRATION CHECKLIST",
      "line": 392
    },
    {
      "type": "text",
      "section": "PN ADMINISTRATION CHECKLIST",
      "line": 394,
      "preview": "- A listing of actions in the PN delivery sequence to ensure that no step is forgotten"
    },
    {
      "type": "text",
      "section": "PN ADMINISTRATION CHECKLIST",
      "line": 395,
      "preview": "- Addresses failures due to distraction or concentration rather than errors due to lack of experienc"
    },
    {
      "type": "text",
      "section": "PN ADMINISTRATION CHECKLIST",
      "line": 396,
      "preview": "- Focus on key problem areas"
    },
    {
      "type": "text",
      "section": "PN ADMINISTRATION CHECKLIST",
      "line": 397,
      "preview": "- Aseptic technique"
    },
    {
      "type": "text",
      "section": "PN ADMINISTRATION CHECKLIST",
      "line": 398,
      "preview": "- Verification"
    },
    {
      "type": "text",
      "section": "PN ADMINISTRATION CHECKLIST",
      "line": 399,
      "preview": "- Tubing connections"
    },
    {
      "type": "text",
      "section": "PN ADMINISTRATION CHECKLIST",
      "line": 400,
      "preview": "- Initiation, maintenance of infusion"
    },
    {
      "type": "text",
      "section": "PN ADMINISTRATION CHECKLIST",
      "line": 401,
      "preview": "- Monitoring"
    },
    {
      "type": "text",
      "section": "PN ADMINISTRATION CHECKLIST",
      "line": 403,
      "preview": "--- page 17 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ADMINISTRATION STEPS: EN AND PN, CONT.",
      "line": 405
    },
    {
      "type": "heading",
      "level": 2,
      "section": "- The Administration Procedures for Nutrition Support",
      "line": 407
    },
    {
      "type": "text",
      "section": "- The Administration Procedures for Nutrition Support",
      "line": 409,
      "preview": "- Maintain infusion at prescribed rate"
    },
    {
      "type": "text",
      "section": "- The Administration Procedures for Nutrition Support",
      "line": 410,
      "preview": "- Use nurse-driven protocols for EN administration"
    },
    {
      "type": "text",
      "section": "- The Administration Procedures for Nutrition Support",
      "line": 411,
      "preview": "- Avoid interruptions of PN and EN for routine care or GRVs $<500 \\mathrm{~mL}$"
    },
    {
      "type": "text",
      "section": "- The Administration Procedures for Nutrition Support",
      "line": 412,
      "preview": "- Limit \"NPO\" periods for EN"
    },
    {
      "type": "text",
      "section": "- The Administration Procedures for Nutrition Support",
      "line": 413,
      "preview": "- Do not adjust PN rate for infusions that are off schedule"
    },
    {
      "type": "text",
      "section": "- The Administration Procedures for Nutrition Support",
      "line": 414,
      "preview": "- Implement guidelines for medication administration with EN and co-infusion of medication with PN"
    },
    {
      "type": "text",
      "section": "- The Administration Procedures for Nutrition Support",
      "line": 415,
      "preview": "- Maintain infection control measures"
    },
    {
      "type": "text",
      "section": "- The Administration Procedures for Nutrition Support",
      "line": 417,
      "preview": "Worthington P et al. JPEN J Parenter Enter Nutr. 2017;41:324-377."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "HANG TIMES: EN FORMULATIONS",
      "line": 419
    },
    {
      "type": "image",
      "section": "HANG TIMES: EN FORMULATIONS",
      "line": 421,
      "content": "![img-9.jpeg](images/92c21018eee2d684.png)"
    },
    {
      "type": "text",
      "section": "HANG TIMES: EN FORMULATIONS",
      "line": 423,
      "preview": "--- page 18 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "HANG TIMES: PN AND ILE",
      "line": 425
    },
    {
      "type": "heading",
      "level": 2,
      "section": "- PN Containers and Administration Tubing and Filters",
      "line": 427
    },
    {
      "type": "text",
      "section": "- PN Containers and Administration Tubing and Filters",
      "line": 429,
      "preview": "- Change administration set and filter every 24 hours, with new container"
    },
    {
      "type": "text",
      "section": "- PN Containers and Administration Tubing and Filters",
      "line": 430,
      "preview": "\" TNA"
    },
    {
      "type": "text",
      "section": "- PN Containers and Administration Tubing and Filters",
      "line": 431,
      "preview": "\" Dextrose/amino acid PN formulations (2-in-1)"
    },
    {
      "type": "text",
      "section": "- PN Containers and Administration Tubing and Filters",
      "line": 432,
      "preview": "- ILE that is administered as a separate infusion must be completed within 12 hours of initiating th"
    },
    {
      "type": "text",
      "section": "- PN Containers and Administration Tubing and Filters",
      "line": 433,
      "preview": "- For ILE infusions longer than 12 hours, divide dose with new container and change administration t"
    },
    {
      "type": "text",
      "section": "- PN Containers and Administration Tubing and Filters",
      "line": 435,
      "preview": "Worthington P et al. JPEN J Parenter Enter Nutr. 2017;41:324-77."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 437
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 439,
      "preview": "- Patient experiences several episodes of hypotension requiring vasopressor support"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 440,
      "preview": "- Abdominal pain did not resolve and her abdomen becomes distended with no bowel sounds"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 441,
      "preview": "- Surgical evaluation reveals ischemic bowel"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 442,
      "preview": "- Another 75 cm of small intestine removed"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 443,
      "preview": "- EN discontinued; PN is to be initiated"
    },
    {
      "type": "text",
      "section": "ASHLEY'S CASE CONTINUES",
      "line": 445,
      "preview": "--- page 19 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "IS PPN A REASONABLE CHOICE?",
      "line": 447
    },
    {
      "type": "text",
      "section": "IS PPN A REASONABLE CHOICE?",
      "line": 449,
      "preview": "- Not suitable for patients with hypermetabolism or a catabolic state"
    },
    {
      "type": "text",
      "section": "IS PPN A REASONABLE CHOICE?",
      "line": 450,
      "preview": "- Requires relatively large fluid volumes"
    },
    {
      "type": "text",
      "section": "IS PPN A REASONABLE CHOICE?",
      "line": 451,
      "preview": "- Use as supplemental PN or a bridge therapy:"
    },
    {
      "type": "text",
      "section": "IS PPN A REASONABLE CHOICE?",
      "line": 452,
      "preview": "- Oral intake or EN is suboptimal"
    },
    {
      "type": "text",
      "section": "IS PPN A REASONABLE CHOICE?",
      "line": 453,
      "preview": "- Avoids risks inherent to central line placement"
    },
    {
      "type": "text",
      "section": "IS PPN A REASONABLE CHOICE?",
      "line": 454,
      "preview": "- Central line access not feasible"
    },
    {
      "type": "text",
      "section": "IS PPN A REASONABLE CHOICE?",
      "line": 455,
      "preview": "- Maximum duration of 10-14 days"
    },
    {
      "type": "text",
      "section": "IS PPN A REASONABLE CHOICE?",
      "line": 456,
      "preview": "- Better nutrient provision with osmolality limit of $900 \\mathrm{mOsm} / \\mathrm{L}$"
    },
    {
      "type": "text",
      "section": "IS PPN A REASONABLE CHOICE?",
      "line": 457,
      "preview": "- Associated with increased rates of infusion phlebitis"
    },
    {
      "type": "text",
      "section": "IS PPN A REASONABLE CHOICE?",
      "line": 459,
      "preview": "Worthington P. JPEN J Parenter Enteral Nutr. 2017; 41:324-77."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SWITCHING TO PN: TIMING",
      "line": 461
    },
    {
      "type": "text",
      "section": "SWITCHING TO PN: TIMING",
      "line": 463,
      "preview": "- Initiate PN after 7 days for well-nourished, stable adult patients who have been unable to receive"
    },
    {
      "type": "text",
      "section": "SWITCHING TO PN: TIMING",
      "line": 464,
      "preview": "- Initiate PN within 3-5 days in those who are nutritionally at-risk and unlikely to achieve desired"
    },
    {
      "type": "text",
      "section": "SWITCHING TO PN: TIMING",
      "line": 465,
      "preview": "- Initiate PN as soon as is feasible for patients with baseline moderate or severe malnutrition in w"
    },
    {
      "type": "text",
      "section": "SWITCHING TO PN: TIMING",
      "line": 466,
      "preview": "- Delay the initiation of PN in a patient with severe metabolic instability until the patient's cond"
    },
    {
      "type": "text",
      "section": "SWITCHING TO PN: TIMING",
      "line": 468,
      "preview": "--- page 20 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF ASSESSMENT \\#6",
      "line": 470
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#6",
      "line": 472,
      "preview": "PN is initiated for nutritional support. On the second night the nurse calls the pharmacy to report "
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#6",
      "line": 473,
      "preview": "A. Silence the alarm"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#6",
      "line": 474,
      "preview": "B. Send a new filter to the unit"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#6",
      "line": 475,
      "preview": "C. Remove the filter and continue the infusion"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#6",
      "line": 476,
      "preview": "D. Stop the infusion and review the PN formulation"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF ASSESSMENT \\#6",
      "line": 478
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#6",
      "line": 480,
      "preview": "PN is initiated for nutritional support. On the second night the nurse calls the pharmacy to report "
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#6",
      "line": 481,
      "preview": "A. Silence the alarm"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#6",
      "line": 482,
      "preview": "B. Send a new filter to the unit"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#6",
      "line": 483,
      "preview": "C. Remove the filter and continue the infusion"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#6",
      "line": 484,
      "preview": "D. Stop the infusion and review the PN formulation"
    },
    {
      "type": "text",
      "section": "SELF ASSESSMENT \\#6",
      "line": 486,
      "preview": "--- page 21 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "OCCLUDED PN FILTERS",
      "line": 488
    },
    {
      "type": "text",
      "section": "OCCLUDED PN FILTERS",
      "line": 490,
      "preview": "- High pressure pump alarms and occluded filters"
    },
    {
      "type": "text",
      "section": "OCCLUDED PN FILTERS",
      "line": 491,
      "preview": "- Incorrect size filter used?"
    },
    {
      "type": "text",
      "section": "OCCLUDED PN FILTERS",
      "line": 492,
      "preview": "- Verify pressure setting on pump"
    },
    {
      "type": "text",
      "section": "OCCLUDED PN FILTERS",
      "line": 493,
      "preview": "- Precipitate or particulate matter present"
    },
    {
      "type": "image",
      "section": "OCCLUDED PN FILTERS",
      "line": 494,
      "content": "![img-10.jpeg](images/97a56f6a3595dc6d.png)"
    },
    {
      "type": "text",
      "section": "OCCLUDED PN FILTERS",
      "line": 496,
      "preview": "CC Image courtesy of British Columbia Institute of Technology (BCIT)."
    },
    {
      "type": "text",
      "section": "OCCLUDED PN FILTERS",
      "line": 498,
      "preview": "- Rule out mechanical or thrombotic causes"
    },
    {
      "type": "text",
      "section": "OCCLUDED PN FILTERS",
      "line": 499,
      "preview": "- Stop the PN infusion"
    },
    {
      "type": "text",
      "section": "OCCLUDED PN FILTERS",
      "line": 500,
      "preview": "- Remove and replace filter"
    },
    {
      "type": "text",
      "section": "OCCLUDED PN FILTERS",
      "line": 501,
      "preview": "- Pharmacy must review PN formulation for precipitates, incompatibilities, or cracked emulsions?"
    },
    {
      "type": "text",
      "section": "OCCLUDED PN FILTERS",
      "line": 502,
      "preview": "- Never allow infusion of unfiltered PN and ILE formulations"
    },
    {
      "type": "text",
      "section": "OCCLUDED PN FILTERS",
      "line": 504,
      "preview": "Ayers P et al. JPEN J Parenter Enteral Nutr. 2014; 38:296-333."
    },
    {
      "type": "text",
      "section": "OCCLUDED PN FILTERS",
      "line": 505,
      "preview": "Worthington et al. Nutr Clin Prad. 2021 Feb; 36(1):29-39."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "RECOMMENDATIONS: FILTERS FOR PN AND ILE",
      "line": 507
    },
    {
      "type": "text",
      "section": "RECOMMENDATIONS: FILTERS FOR PN AND ILE",
      "line": 509,
      "preview": "- In-line filters are required on all PN and ILE infusions"
    },
    {
      "type": "text",
      "section": "RECOMMENDATIONS: FILTERS FOR PN AND ILE",
      "line": 510,
      "preview": "- In-line filters serve to reduce exposure to particulate matter during PN administration"
    },
    {
      "type": "text",
      "section": "RECOMMENDATIONS: FILTERS FOR PN AND ILE",
      "line": 511,
      "preview": "- A 1.2 micron in-line filter is recommended for administration of both TNAs and 2-in-1 PNs"
    },
    {
      "type": "text",
      "section": "RECOMMENDATIONS: FILTERS FOR PN AND ILE",
      "line": 512,
      "preview": "- For TNAs, place the filter as close to the catheter hub as possible"
    },
    {
      "type": "text",
      "section": "RECOMMENDATIONS: FILTERS FOR PN AND ILE",
      "line": 513,
      "preview": "- For 2-in-1 PNs, place the filter below the Y-site where the dextrose-amino acid admixture and the "
    },
    {
      "type": "text",
      "section": "RECOMMENDATIONS: FILTERS FOR PN AND ILE",
      "line": 514,
      "preview": "- This practice is supported by decades of experience in hospital and home PN administration setting"
    },
    {
      "type": "text",
      "section": "RECOMMENDATIONS: FILTERS FOR PN AND ILE",
      "line": 516,
      "preview": "--- page 22 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "RECOMMENDATIONS: FILTERS FOR PN AND ILE",
      "line": 518
    },
    {
      "type": "image",
      "section": "RECOMMENDATIONS: FILTERS FOR PN AND ILE",
      "line": 520,
      "content": "![img-11.jpeg](images/570710a76f0e1412.png)"
    },
    {
      "type": "image",
      "section": "RECOMMENDATIONS: FILTERS FOR PN AND ILE",
      "line": 522,
      "content": "![img-12.jpeg](images/2697c2d58769f8d3.png)"
    },
    {
      "type": "text",
      "section": "RECOMMENDATIONS: FILTERS FOR PN AND ILE",
      "line": 524,
      "preview": "*Worthington et al. Nutr Clin Pract. 2021 Feb; 36(1):29-39.*"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "WEANING PN",
      "line": 526
    },
    {
      "type": "image",
      "section": "WEANING PN",
      "line": 528,
      "content": "![img-13.jpeg](images/b3b9d8483eb30de7.png)"
    },
    {
      "type": "text",
      "section": "WEANING PN",
      "line": 530,
      "preview": "- Wean PN when oral intake and/or EN achieves 50%-75% of requirements for energy, protein, and micro"
    },
    {
      "type": "text",
      "section": "WEANING PN",
      "line": 531,
      "preview": "- Continue PN when impaired GI function precludes 100% absorption of nutrient needs."
    },
    {
      "type": "text",
      "section": "WEANING PN",
      "line": 532,
      "preview": "- Consider using a weaning protocol during the transition from PN to EN."
    },
    {
      "type": "text",
      "section": "WEANING PN",
      "line": 534,
      "preview": "--- page 23 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#1",
      "line": 536
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 538,
      "preview": "A 61-year-old woman with a history of Crohn's disease, develops persistent nausea and vomiting. X-ra"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 539,
      "preview": "A. Low residue oral diet"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 540,
      "preview": "B. Parenteral nutrition"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 541,
      "preview": "C. Peripheral intravenous fluids"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 542,
      "preview": "D. Tube feeding"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#1",
      "line": 544
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 546,
      "preview": "A 61-year-old woman with a history of Crohn's disease, develops persistent nausea and vomiting. X-ra"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 547,
      "preview": "A. Low residue oral diet"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 548,
      "preview": "B. Parenteral nutrition"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 549,
      "preview": "C. Peripheral intravenous fluids"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 550,
      "preview": "D. Tube feeding"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 552,
      "preview": "--- page 24 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#2",
      "line": 554
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 556,
      "preview": "A 28 year old man was admitted to the ICU 7 days ago with multiple trauma following a motor vehicle "
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 557,
      "preview": "A. The osmolality limit for PPN is set at 600 mOsm/L"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 558,
      "preview": "B. The expected duration of therapy should be greater than 2 weeks."
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 559,
      "preview": "C. Peripheral PN avoids the risks associated with central line placement"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 560,
      "preview": "D. Peripheral PN is most appropriate for use with hypermetabolic conditions"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#2",
      "line": 562
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 564,
      "preview": "A 28 year old man was admitted to the ICU 7 days ago with multiple trauma following a motor vehicle "
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 565,
      "preview": "A. The osmolality limit for PPN is set at 600 mOsm/L"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 566,
      "preview": "B. The expected duration of therapy should be greater than 2 weeks."
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 567,
      "preview": "C. Peripheral PN avoids the risks associated with central line placement"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 568,
      "preview": "D. Peripheral PN is most appropriate for use with hypermetabolic conditions"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 570,
      "preview": "--- page 25 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "CONCLUSIONS",
      "line": 572
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 574,
      "preview": "- Judicious selection of candidates for nutrition support is essential for achieving optimal patient"
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 575,
      "preview": "- Use clinical assessment, rather than medical diagnosis, to identify candidates for PN , as well as"
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 576,
      "preview": "- Establish protocols for initiating and administering nutrition support therapy that incorporate gu"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "REFERENCES",
      "line": 579
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 581,
      "preview": "- American Association of Critical-Care Nurses. AACN Practice Alert: Initial and Ongoing Verificatio"
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 582,
      "preview": "- AHRQ. PSNet. The wrong channel. https://psnet.ahrq.gov/cases/case/103 (accessed 2019 Mar 14)."
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 583,
      "preview": "- Ayers P, Adams S, Boulatta J et al. A.S.P.E.N. Parenteral nutrition safety consensus recommendatio"
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 584,
      "preview": "- Boullata JI, Carrera AL, Harvey L et al. ASPEN safe practices for enteral nutrition therapy. JPEN "
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 585,
      "preview": "- Cohen MR, Smetzer JL. ISMP Medication Error Report Analysis. Hospital Pharmacy. 2010; 45:191-95."
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 586,
      "preview": "- GEDSA. ENFit ${ }^{\\circledR}$ Advocacy Meeting. 2017 Jul. http://stayconnected.org/wp-content/upl"
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 588,
      "preview": "--- page 26 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "REFERENCES, CONT.",
      "line": 590
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 592,
      "preview": "- Food and Drug Administration. Feeding Tube Placement Systems: Letter to Health Care Providers - Re"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 593,
      "preview": "- Food and Drug Administration: Examples of Medical Device Misconnections. (2017 Dec). https://www.f"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 594,
      "preview": "- ISMP Medication Alert. Safety Brief: IV fat emulsion needs a filter. 2016; 21(1):3-4."
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 595,
      "preview": "- Lipman T. Grains or veins: is enteral nutrition really better than parenteral nutrition? A look at"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 596,
      "preview": "- McClave SA, DiBaise JK, Mullin GE et al. ACG Clinical Guideline: Nutrition Therapy in the Adult Ho"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 598,
      "preview": "NUTRITION SUPPORT"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 599,
      "preview": "CERTIFICATE"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "REFERENCES, CONT.",
      "line": 601
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 603,
      "preview": "- Simmons D, Symes L, Guenter P, et al. Tubing misconnections: Normalization of deviance. Nutr Clin "
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 604,
      "preview": "- The Joint Commission. Sentinel Event Alert 53: Managing risk during transition to new ISO tubing c"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 605,
      "preview": "- Seres DS, Valcarcel M, Guillaume A. Advantages of enteral nutrition over parenteral nutrition. The"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 606,
      "preview": "- Sorokin R, Gottlieb JE. Enhancing patient safety during feeding tube insertion: a review of more t"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 607,
      "preview": "- Worthington P, Gura KM, Kraft MD, Nishikawa R, Guenter P, Sacks GS; ASPEN PN Safety Committee. Upd"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 609,
      "preview": "--- page 27 ---"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 611,
      "preview": "NUTRITION SUPPORT CERTIFICATE"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 613,
      "preview": "--- page 28 ---"
    },
    {
      "type": "image",
      "section": "REFERENCES, CONT.",
      "line": 615,
      "content": "![img-14.jpeg](images/bf110b5d089b8533.png)"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 617,
      "preview": "Andrew Mays, Pharm.D., BSNCP, CNCS"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 618,
      "preview": "Clinical Pharmacy Specialist"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 619,
      "preview": "University of Mississippi Medical Center"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 620,
      "preview": "Clinical Assistant Professor"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 621,
      "preview": "University of Mississippi"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 622,
      "preview": "Jackson, Mississippi"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 624,
      "preview": "Andrew Mays is a clinical pharmacy specialist in nutrition support at the University of Mississippi "
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 626,
      "preview": "He has served as member of the ASHP Council on Therapeutics, member and chair of the ASHP New Practi"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 628,
      "preview": "--- page 29 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Relevant Financial Relationship Disclosure",
      "line": 630
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 632,
      "preview": "In accordance with our accreditor\u2019s Standards of Integrity and Independence in Accredited Continuing"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 634,
      "preview": "An ineligible company is any entity producing, marketing, re-selling, or distributing health care go"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 636,
      "preview": "The following persons in control of this activity\u2019s content have relevant financial relationships:"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 638,
      "preview": "- Phil Ayers: Fresenius Kabi, consultant and speaker"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 639,
      "preview": "- David Evans: Fresenius Kabi, consultant and speaker; Abbott Laboratories, consultant and speaker; "
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 640,
      "preview": "- Andrew Mays: Fresenius Kabi, speaker"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 641,
      "preview": "- Jay Mirtallo: Fresenius Kabi, consultant"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 642,
      "preview": "- Kris Mogensen: Baxter, speaker; ThriveRx, advisory board; Pfizer, advisory board"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 644,
      "preview": "All other persons in control of content do not have any relevant financial relationships with an ine"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 646,
      "preview": "As required by the Standards of Integrity and Independence in Accredited Continuing Education defini"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Methods and CE Requirements",
      "line": 648
    },
    {
      "type": "text",
      "section": "Methods and CE Requirements",
      "line": 650,
      "preview": "This online activity consists of a combined total of 12 learning modules. Pharmacists and physicians"
    },
    {
      "type": "text",
      "section": "Methods and CE Requirements",
      "line": 652,
      "preview": "Participants must participate in the entire activity, complete the evaluation and all required compo"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Important Note \u2013 ACPE 60 Day Deadline:",
      "line": 654
    },
    {
      "type": "text",
      "section": "Important Note \u2013 ACPE 60 Day Deadline:",
      "line": 656,
      "preview": "Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "System Technical Requirements",
      "line": 658
    },
    {
      "type": "text",
      "section": "System Technical Requirements",
      "line": 660,
      "preview": "Courses and learning activities are delivered via your Web browser and Acrobat PDF. Users should hav"
    },
    {
      "type": "text",
      "section": "System Technical Requirements",
      "line": 662,
      "preview": "View Frequently Asked Questions for more information."
    }
  ],
  "images": [
    {
      "sha_name": "412f1b1b557f1ba0.png",
      "original_ref": "img-0.jpeg",
      "page": 1,
      "relative_path": "images/412f1b1b557f1ba0.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/412f1b1b557f1ba0.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "412f1b1b557f1ba0"
    },
    {
      "sha_name": "0670f8c9f5d1d19b.png",
      "original_ref": "img-1.jpeg",
      "page": 6,
      "relative_path": "images/0670f8c9f5d1d19b.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/0670f8c9f5d1d19b.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "0670f8c9f5d1d19b"
    },
    {
      "sha_name": "8de4a22572ef49a5.png",
      "original_ref": "img-2.jpeg",
      "page": 10,
      "relative_path": "images/8de4a22572ef49a5.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/8de4a22572ef49a5.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "8de4a22572ef49a5"
    },
    {
      "sha_name": "6b2234bd76218919.png",
      "original_ref": "img-3.jpeg",
      "page": 10,
      "relative_path": "images/6b2234bd76218919.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/6b2234bd76218919.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "6b2234bd76218919"
    },
    {
      "sha_name": "7667dd7a76027700.png",
      "original_ref": "img-4.jpeg",
      "page": 12,
      "relative_path": "images/7667dd7a76027700.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/7667dd7a76027700.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "7667dd7a76027700"
    },
    {
      "sha_name": "0701e704546ab79f.png",
      "original_ref": "img-5.jpeg",
      "page": 13,
      "relative_path": "images/0701e704546ab79f.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/0701e704546ab79f.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "0701e704546ab79f"
    },
    {
      "sha_name": "f7fad7555b1a219f.png",
      "original_ref": "img-6.jpeg",
      "page": 13,
      "relative_path": "images/f7fad7555b1a219f.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/f7fad7555b1a219f.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "f7fad7555b1a219f"
    },
    {
      "sha_name": "b1a560055210e9ce.png",
      "original_ref": "img-7.jpeg",
      "page": 14,
      "relative_path": "images/b1a560055210e9ce.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/b1a560055210e9ce.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "b1a560055210e9ce"
    },
    {
      "sha_name": "9aa922bdfe71174f.png",
      "original_ref": "img-8.jpeg",
      "page": 15,
      "relative_path": "images/9aa922bdfe71174f.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/9aa922bdfe71174f.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "9aa922bdfe71174f"
    },
    {
      "sha_name": "92c21018eee2d684.png",
      "original_ref": "img-9.jpeg",
      "page": 17,
      "relative_path": "images/92c21018eee2d684.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/92c21018eee2d684.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "92c21018eee2d684"
    },
    {
      "sha_name": "97a56f6a3595dc6d.png",
      "original_ref": "img-10.jpeg",
      "page": 21,
      "relative_path": "images/97a56f6a3595dc6d.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/97a56f6a3595dc6d.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "97a56f6a3595dc6d"
    },
    {
      "sha_name": "570710a76f0e1412.png",
      "original_ref": "img-11.jpeg",
      "page": 22,
      "relative_path": "images/570710a76f0e1412.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/570710a76f0e1412.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "570710a76f0e1412"
    },
    {
      "sha_name": "2697c2d58769f8d3.png",
      "original_ref": "img-12.jpeg",
      "page": 22,
      "relative_path": "images/2697c2d58769f8d3.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/2697c2d58769f8d3.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "2697c2d58769f8d3"
    },
    {
      "sha_name": "b3b9d8483eb30de7.png",
      "original_ref": "img-13.jpeg",
      "page": 22,
      "relative_path": "images/b3b9d8483eb30de7.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/b3b9d8483eb30de7.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "b3b9d8483eb30de7"
    },
    {
      "sha_name": "bf110b5d089b8533.png",
      "original_ref": "img-14.jpeg",
      "page": 28,
      "relative_path": "images/bf110b5d089b8533.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/7_AdministrationofNutritionSupport,Part1/images/bf110b5d089b8533.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "bf110b5d089b8533"
    }
  ],
  "extraction": {
    "ocr_model": "mistral-ocr-latest",
    "request_id": "local-1754696159",
    "ts": "2025-08-08T23:35:59.031405+00:00"
  }
}